Time above 1500 copies: A viral load measure for assessing transmission risk of HIV-positive patients in care

AIDS

Volumn 29, Issue 8, 2015, Pages 947-954

  Marks, Gary ^a   Gardner, Lytt I ^a   Rose, Charles E ^a   Zinski, Anne ^b   Moore, Richard D ^c   Holman, Susan ^d   Rodriguez, Allan E ^e   Sullivan, Meg ^f   Giordano, Thomas P ^g  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b University of Alabama at Birmingham   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cohort study; HIV; Person Time; Transmission; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE DENSITY RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; UNITED STATES; VIRAL LOAD TESTING; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; AGED; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 85003055672     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000640     Document Type: Article

References (17)

1. Bradley H, Hall I, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV: United States, 20MMWR Morb Mortal Wkly Rep 2014; 63:1113 1117.
2. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012; 26:893 895.
3. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447 1450.
4. Fung ICH, Gambhir M, Sighem AV, Wolf FD, Garnett GP. The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: Are we ready to infer poor adherence? J Acquir Immune Defic Syndr 2012; 60:5 11.
5. Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, et al. Magnitude of virologic blips in associated with a higher risk for virologic rebound in HIV-infected individuals: A recurrent events analysis. J Infect Dis 2012; 205:1230 1238.
6. Murray JM, Zaunders JJ, Koelsch KK, Natarajan V, Badralmaa Y, McBride K, et al. Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels dues to assay underreporting. AIDS Res Hum Retroviruses 2013; 29:1621 1625.
7. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-Analysis. AIDS 2009; 23:1397 1404.
8. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type N Engl J Med 2000; 342:921 929.
9. Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, et al. Male viral load and Heterosexual transmission of HIV-1 subtype E in Northern Thailand. J Acquir Immune Defic Syndr 2002; 29:275 283.
10. Gardner LI, Giordano TP, Marks G, Wilson TE, Craw JA, Drainoni M, et al. Enhanced personal contact with HIV patients across time improves retention in primary care: A randomized trial in six U.S. HIV clinics. Clin Infect Dis 2014; 59:725 734.
11. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (November, 2014). Department of Health and Human Services. http://aidsinfo.nih.gov/Content Files/AdultandAdolescentGL.pdf.
12. Gunthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral treatment of adult HIV infection 2014 recommendations of the International Antiviral Society-USA panel. JAMA 2014; 312:410 425.
13. Gardner LI, Marks G, Craw J, Wilson T, Drainoni ML, Moore R, et al. A low-effort clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis 2012; 55:1124 1134.
14. Golin C, Marks G, Wright J, Gerkovich M, Tien HC, Patel SN, et al. Psychosocial characteristics and sexual behaviors of people in care for HIV infection: An examination of men who have sex with men, heterosexual men, and women. AIDS Behav 2009; 13:1129 1142.
15. CDC. Increase in newly diagnosed HIV infections among young black men who have sex with men: Milwaukee County, Wisconsin, 1999 2008.MMWRMorb Mortal Wkly Rep 2011; 60:99 102.
16. CDC. Vital signs: HIV prevention through care and treatment: United States. MMWR Morb Mortal Wkly Rep 2011; 60:1618 1623.
17. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in care among HIV-diagnosed persons: A meta-Analysis. AIDS 2010; 24:2665 2678